Article
APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.
Neurology - 28 Jan 2003
Tsuboi Yoshio, Josephs Keith A, Cookson Natalie, Dickson Dennis W
Abstract excerpt
OBJECTIVE: To assess demographic and genetic determinants of Alzheimer type pathology in progressive supranuclear palsy (PSP). METHODS: From a total of 173 pathologically proven cases of PSP in the Society for PSP Brain Bank, 143 patients (mean age = 74.4 years, ranging from 42 to 98 years) were suitable for genetic and pathologic study. Senile plaques (SPs) and neurofibrillary tangles (NFTs) were counted in five...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
